1. Home
  2. SNN vs ALGN Comparison

SNN vs ALGN Comparison

Compare SNN & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNN
  • ALGN
  • Stock Information
  • Founded
  • SNN 1856
  • ALGN 1997
  • Country
  • SNN United Kingdom
  • ALGN United States
  • Employees
  • SNN N/A
  • ALGN N/A
  • Industry
  • SNN Industrial Specialties
  • ALGN Industrial Specialties
  • Sector
  • SNN Health Care
  • ALGN Health Care
  • Exchange
  • SNN Nasdaq
  • ALGN Nasdaq
  • Market Cap
  • SNN 12.3B
  • ALGN 12.4B
  • IPO Year
  • SNN 1999
  • ALGN N/A
  • Fundamental
  • Price
  • SNN $25.93
  • ALGN $171.41
  • Analyst Decision
  • SNN Hold
  • ALGN Buy
  • Analyst Count
  • SNN 3
  • ALGN 12
  • Target Price
  • SNN $27.00
  • ALGN $262.64
  • AVG Volume (30 Days)
  • SNN 1.2M
  • ALGN 1.3M
  • Earning Date
  • SNN 02-25-2025
  • ALGN 04-30-2025
  • Dividend Yield
  • SNN 2.89%
  • ALGN N/A
  • EPS Growth
  • SNN 56.15
  • ALGN N/A
  • EPS
  • SNN 0.47
  • ALGN 5.62
  • Revenue
  • SNN $5,810,000,000.00
  • ALGN $3,999,012,000.00
  • Revenue This Year
  • SNN $6.42
  • ALGN $4.40
  • Revenue Next Year
  • SNN $5.03
  • ALGN $6.59
  • P/E Ratio
  • SNN $27.69
  • ALGN $30.50
  • Revenue Growth
  • SNN 4.70
  • ALGN 3.54
  • 52 Week Low
  • SNN $23.65
  • ALGN $141.74
  • 52 Week High
  • SNN $31.72
  • ALGN $327.49
  • Technical
  • Relative Strength Index (RSI)
  • SNN 41.26
  • ALGN 54.56
  • Support Level
  • SNN $25.63
  • ALGN $162.27
  • Resistance Level
  • SNN $26.32
  • ALGN $168.88
  • Average True Range (ATR)
  • SNN 0.74
  • ALGN 10.32
  • MACD
  • SNN -0.13
  • ALGN 2.61
  • Stochastic Oscillator
  • SNN 41.06
  • ALGN 98.83

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: